Elara Pharmaceuticals
Latest round
- Series A
Last raised
- Nov 2009
Total raised
- $6.9M
Investors
- 3
About Elara Pharmaceuticals
Elara Pharmaceuticals GmbH is a biopharmaceutical company. It focuses on the discovery and development of hypoxia inducible factor (HIF) antagonizing drugs for the treatment of multiple myeloma, tumors, and taxane-resistant cancers.
Who invested in Elara Pharmaceuticals
3 investors across 1 round
See all investors in Elara Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 26, 2009
Amount
$6.9M
Investors
Questions about Elara Pharmaceuticals
Who invested in Elara Pharmaceuticals?
Elara Pharmaceuticals has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Elara Pharmaceuticals raised?
Elara Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Elara Pharmaceuticals last raise money?
Elara Pharmaceuticals's most recent round on record is a Series A, in Nov 2009.
What does Elara Pharmaceuticals do?
Elara Pharmaceuticals GmbH is a biopharmaceutical company.
Where is Elara Pharmaceuticals headquartered?
Elara Pharmaceuticals is headquartered in Heidelberg, Germany.
Which VCs invest in companies like Elara Pharmaceuticals?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Elara Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Elara Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.